Is docetaxel-carboplatin an alternative to paclitaxel-carboplatin in ovarian cancer?

被引：0
|
作者：
Vasey, PA
Coleman, R
Eggleton, SPH
Graham, J
Fleming, D
Paul, J
Reed, NS
Kaye, S
机构：
[1] CRC, Dept Med Oncol, Glasgow, Lanark, Scotland
[2] Weston Pk Hosp, Sheffield, S Yorkshire, England
[3] Bristol Oncol Ctr, Bristol, Avon, England
来源：
BRITISH JOURNAL OF CANCER | 1999年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
213
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [21] RANDOMIZED PHASE II STUDY OF PACLITAXEL-CARBOPLATIN (PC) VERSUS GEMCITABINE-CARBOPLATIN (GC) FOLLOWED BY PACLITAXEL-CARBOPLATIN (PC) IN PLATINUM-SENSITIVE RECURRENT OVARIAN CARCINOMA (PSROC): A GEICO (SPANISH GROUP FOR INVESTIGATION IN OVARIAN CANCER) STUDY
    Martin, A. Gonzalez
    Casado, A.
    Arranz, J.
    Rubio, M. J.
    Calvo, E.
    Beltran, M.
    Mendiola, C.
    Sanchez, A.
    Santaballa, A.
    Cervantes, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 307 - 307
  • [22] Sequential gemcitabine-carboplatin followed by paclitaxel-carboplatin in the first-line treatment of advanced ovarian cancer:: A phase II study
    Mäenpää, JU
    Grénman, SE
    Jalkanen, JT
    Kuoppala, TA
    Leminen, AO
    Puistola, US
    Vuolo-Merilä, PM
    Yliskoski, MH
    GYNECOLOGIC ONCOLOGY, 2006, 101 (01) : 114 - 119
  • [23] Paclitaxel-carboplatin induced radiation recall colitis
    Kundak, I
    Oztop, H
    Soyturk, M
    Ozcan, MA
    Yilmaz, U
    Meydan, N
    Gorken, LB
    Kupelioglu, A
    Alakavuklar, M
    TUMORI, 2004, 90 (02) : 256 - 258
  • [24] Feasibility study comparing docetaxel-cisplatin versus docetaxel-carboplatin as first-line chemotherapy for ovarian cancer
    Minagawa, Y
    Kigawa, J
    Kanamori, Y
    Itamochi, H
    Terakawa, N
    Okada, M
    Kitada, F
    GYNECOLOGIC ONCOLOGY, 2006, 101 (03) : 495 - 498
  • [25] Effects of sequential paclitaxel-carboplatin followed by gemcitabine-based chemotherapy compared with paclitaxel-carboplatin therapy administered to patients with advanced epithelial ovarian cancer A retrospective, STROBE-compliant study
    Wang, Fei
    Du, Xuelian
    Li, Xiaoxia
    Liu, Naifu
    Yu, Hao
    Sheng, Xiugui
    MEDICINE, 2016, 95 (51) : e5696
  • [26] Paclitaxel plus carboplatin in the treatment of ovarian cancer
    Ozols, RF
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 84 - 89
  • [27] Carboplatin-paclitaxel- and carboplatin-docetaxel-induced cytotoxic effect in epithelial ovarian carcinoma in vitro
    Engblom, P
    Rantanen, V
    Kulmala, J
    Grènman, S
    CANCER, 1999, 86 (10) : 2066 - 2073
  • [28] Factors contributing to carboplatin blockade and interruption in its route of administration in paclitaxel-carboplatin therapy
    Inoue, Motoki
    Nakadate, Kazuhiko
    Oosaki, Mami
    Shirota, Mikio
    Yasu, Takeo
    DRUG DISCOVERIES AND THERAPEUTICS, 2023, 17 (03): : 214 - 216
  • [29] Randomized phase III study comparing paclical-carboplatin with paclitaxel-carboplatin in patients with recurrent platinum-sensitive epithelial ovarian cancer.
    Vergote, Ignace
    Brize, Arija
    Lisyanskaya, Alla Sergeevua
    Lichinitser, Mikhail
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] Comparison of paclitaxel liposomes combined with carboplatin versus paclitaxel combined with carboplatin in the treatment of advanced ovarian cancer
    Tan, Xiangbin
    Zou, Shuangyou
    Chen, Hui
    Chen, Dachao
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (09)
12345